

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Gilteritinib iyimithi yomdlavuza eqondiwe esiza ukwelapha uhlobo oluthile lwe-acute myeloid leukemia (AML). Le mithi yomlomo isebenza ngokuvimba amaprotheni athile asiza amaseli omdlavuza ukuthi akhule futhi ande, inike umzimba wakho ithuba elingcono lokulwa nalesi sifo.
Uma wena noma othile omkhathalelayo enikwe i-gilteritinib, kungokwemvelo ukuthi ube nemibuzo mayelana nokuthi isebenza kanjani nokuthi yini ongayilindela. Le mithi imelela intuthuko ebalulekile ekwelapheni i-AML, ikakhulukazi kubantu abanomdlavuza onezinguquko ezithile zofuzo ezibizwa ngokuthi i-FLT3 mutation.
I-Gilteritinib iyimithi kadokotela eyingxenye yeqembu lezidakamizwa ezibizwa ngokuthi ama-kinase inhibitors. Iqondise futhi ivimbe amaprotheni abizwa ngokuthi i-FLT3 ne-AXL asetshenziswa amaseli omdlavuza ukuthi akhule futhi asinde.
Le mithi iza ngamaphilisi owathatha ngomlomo, okwenza ukwelashwa kube lula kunezinye izindlela zokwelapha umdlavuza. Udokotela wakho uzonquma i-gilteritinib ngokuya ngohlobo lwakho oluthile lwe-leukemia nokuthi amaseli akho omdlavuza anawo yini izimpawu ezithile zofuzo ezenza lokhu kwelashwa kuphumelele.
Imithi isebenza ngaphakathi emzimbeni wakho ukuphazamisa amasignali atshela amaseli omdlavuza ukuthi ande. Ngokuvimba lezi zindlela, i-gilteritinib ingasiza ukunciphisa noma ukumisa ukukhula kwamaseli e-leukemia ngenkathi ivumela amaseli akho egazi anempilo ukuthi alulame.
I-Gilteritinib isetshenziswa ikakhulukazi ukwelapha abantu abadala abane-acute myeloid leukemia (AML) enezinguquko ezithile zofuzo ezibizwa ngokuthi i-FLT3 mutations. Udokotela wakho uzosebenzisa le mithi uma i-leukemia yakho ibuyile ngemva kokwelashwa kwangaphambilini noma ingazange isabele kahle kwezinye izindlela zokwelapha.
I-AML wuhlobo lomdlavuza wegazi oluthinta umnkantsha wakho wamathambo, lapho umzimba wakho wenza khona amaseli egazi. Uma une-AML, umnkantsha wakho wamathambo ukhiqiza amaseli amaningi amhlophe egazi angajwayelekile angasebenzi kahle, acindezela amaseli egazi anempilo.
Ushintsho lwe-FLT3 lwenzeka cishe kuma-30% abantu abane-AML. Lolu shintsho lofuzo lwenza amaprotheni athile asebenze ngokweqile, okubangela ukuthi amaseli omdlavuza akhule ngokushesha. I-Gilteritinib iqondise ngqo lawa maprotheni asebenza ngokweqile, yingakho udokotela wakho edinga ukuhlola amaseli akho omdlavuza ngaphambi kokukuyalela lo muthi.
I-Gilteritinib isebenza ngokuvimba amaprotheni athile abizwa nge-FLT3 ne-AXL asebenza njengamashintshi ngaphakathi kwamaseli omdlavuza. Lapho la maprotheni evuliwe, athumela amasignali etshela amaseli omdlavuza ukuthi akhule, aphindaphindeke, futhi asinde.
Cabanga ngala maprotheni njengamaphampu kaphethiloli agcina amaseli omdlavuza esebenza. I-Gilteritinib isebenza njenge-valve yokuvala, imisa ukuhlinzekwa kukaphethiloli okudingwa amaseli omdlavuza ukuze achume. Le ndlela eqondiwe ithathwa njengokwelashwa komdlavuza okuphakathi nendawo kuya kokunamandla, njengoba iphazamisa ngqo izindlela zokukhula komdlavuza.
Ngokungafani ne-chemotherapy ethinta wonke amaseli ahlukanisa ngokushesha, i-gilteritinib yakhelwe ukuba ikhetheke kakhulu. Iqondise ikakhulukazi amaseli anoshintsho lwe-FLT3, okungasiza ukunciphisa eminye imiphumela emibi ngenkathi isasebenza ngokuphikisana ne-leukemia yakho.
Thatha i-gilteritinib ngendlela eqondile udokotela wakho ayiyalela ngayo, ngokuvamile kanye ngosuku cishe ngesikhathi esifanayo nsuku zonke. Ungayithatha ngaphandle kokudla noma ngaphandle kokudla, kodwa zama ukungaguquguquki ngokukhetha kwakho ukusiza umzimba wakho ukuba umunce umuthi ngendlela elindelekile.
Gwinya amaphilisi wonke ngenkomishi yamanzi. Ungawachobozi, uwahlafune, noma uwaphule amaphilisi, ngoba lokhu kungathinta indlela umuthi osebenza ngayo emzimbeni wakho. Uma unenkinga yokugwinya amaphilisi, khuluma nethimba lakho lezempilo ngamasu angasiza.
Kungcono ukuthatha i-gilteritinib lapho isisu sakho singekabi nalutho. Ukudla ukudla okulula noma ukudla ngaphambi kokuthatha umthamo wakho kungasiza ukunciphisa isisu esibuhlungu. Gwema ama-grapefruit nejusi le-grapefruit ngenkathi uthatha lo muthi, njengoba kungakhuphula inani lomuthi egazini lakho liye emazingeni angaba yingozi.
Qhubeka nokuthatha i-gilteritinib ngisho nasezinsukwini lapho ungezwa kahle, ngaphandle uma udokotela wakho ekutshela ukuthi uyeke. Ukuqina kubalulekile ukuze umuthi usebenze ngempumelelo ngokumelene nomdlavuza wakho wegazi.
Ubude bokwelashwa nge-gilteritinib buhlukahluka kakhulu kumuntu nomuntu futhi kuncike ekutheni umdlavuza wakho wegazi uphendula kahle kangakanani emuthini. Abanye abantu bangase bayithathe izinyanga eziningana, kanti abanye bangase bayidinge unyaka noma ngaphezulu.
Udokotela wakho uzoqapha inqubekela phambili yakho ngokuhlolwa kwegazi njalo kanye nokuhlolwa komnkantsha wamathambo. Lokhu kuhlolwa kusiza ukunquma ukuthi umuthi uyasebenza yini nokuthi umzimba wakho uyawuthwala yini kahle. Ngokusekelwe kulezi ziphumo, udokotela wakho uzoquma ukuthi uzoqhubeka, ulungise, noma umise ukwelashwa kwakho.
Ungayeki ukuthatha i-gilteritinib ngokwakho, ngisho noma uzizwa ungcono. Umdlavuza wegazi ungabuyela ngokushesha uma ukwelashwa kumiswa ngaphambi kwesikhathi. Ithimba lakho lezempilo lizokuqondisa kunoma yiziphi izinguquko ohlelweni lwakho lokwelashwa olusekelwe ekuphenduleni kwakho komuntu ngamunye nempilo yonke.
Njengayo yonke imithi yomdlavuza, i-gilteritinib ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi emibi ilawuleka ngokunakekelwa okufanele nokuqapha okuvela eqenjini lakho lezempilo.
Ukuqonda ukuthi yini ongayilindela kungakusiza ukuthi uzizwe ulungiseleleke kakhulu futhi wazi ukuthi ungathinta nini ukuthola ukwesekwa. Nawa imiphumela emibi evame kakhulu ongase uyithole:
Le miphumela emibi ivame ukuthuthuka njengoba umzimba wakho ujwayela imithi. Ithimba lakho lezempilo linganikeza amasu okusiza ukuphatha lezi zimpawu futhi ligcine izinga lempilo yakho ngesikhathi sokwelashwa.
Abanye abantu bangase babe nemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha. Nakuba lokhu kungavamile, kubalulekile ukukwazi:
Xhumana nethimba lakho lezempilo ngokushesha uma uhlangabezana nanoma yiziphi zalezi zimpawu ezingathi sína. Zihlomele ukukusiza ukuphatha le miphumela futhi ulungise ukwelashwa kwakho uma kudingeka.
I-Gilteritinib ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungile yini kuwe. Abantu abanezimo ezithile zempilo noma abathatha imithi ethile bangase bangabi ngabakhethiwe abahle kulokhu kwelashwa.
Udktora wakho uzocabangela izinto eziningi ngaphambi kokukuchazela i-gilteritinib ukuqinisekisa ukuthi iphephile esimweni sakho esithile:
Qiniseka ukutshela udktora wakho ngayo yonke imithi, izithasiselo, kanye nemikhiqizo yamakhambi oyithathayo. Futhi khuluma nganoma yimaphi amasu okukhulelwa, njengoba bobabili abesilisa nabesifazane badinga ukusebenzisa izindlela zokulawula inzalo ngesikhathi sokwelashwa nangemva kwesikhashana.
Ithimba lakho lezempilo lizosebenza nawe ukuthola ukuthi i-gilteritinib ilungele yini isimo sakho futhi ikuqaphele eduze ngesikhathi sokwelashwa.
I-Gilteritinib ithengiswa ngaphansi kwegama lomkhiqizo elithi Xospata. Leli yilo kuphela igama lomkhiqizo elitholakalayo njengamanje kulo muthi e-United States.
Lapho uthatha umuthi wakho, uzobona “Xospata” kulebula lebhodlela kanye “ne-gilteritinib” njengegama elivamile. Womabili la magama abhekisela emuthini ofanayo, ngakho-ke ungakhathazeki uma ubona noma iyiphi isetshenziswa emarekhodini akho ezokwelapha noma ezingxoxweni nethimba lakho lezempilo.
Njengamanje, azikho izinhlobo ezivamile ze-gilteritinib ezitholakalayo. Lokhu kusho ukuthi i-Xospata iyona kuphela inketho, engase ithinte ukumbozwa komshwalense kanye nokucatshangelwa kwezindleko ongaxoxa ngakho nethimba lakho lezempilo kanye nekhemisi.
Eminye imithi eminingi ingelapha i-AML, nakuba ukukhetha okungcono kakhulu kuncike ohlotsheni lwakho oluthile lwe-leukemia kanye nezici zempilo yakho. Udokotela wakho uzocabangela ukwakheka kwezakhi zofuzo zomdlavuza wakho, impilo yakho yonke, kanye nokwelashwa kwangaphambilini lapho ehlola ezinye izindlela.
Ezinye izindlela zokwelapha ezihloswe ngqo ze-AML zihlanganisa i-midostaurin (enye i-FLT3 inhibitor) kanye nezinhlanganisela ezihlukahlukene zemithi yamakhemikhali yendabuko. Abanye abantu bangase babe ngabazongenela ukwelashwa okusha njenge-venetoclax ehlanganiswe neminye imithi.
Kwabanye iziguli, izivivinyo zemitholampilo zingase zinikeze ukufinyelela ekwelashweni okungazanywa okungakatholakali kabanzi. Ithimba lakho lokunakekelwa kwezempilo lingakusiza ukuthi uqonde zonke izinketho zakho futhi unqume indlela engcono kakhulu yesimo sakho esithile.
Ukukhethwa kokwelashwa kungokomuntu ngamunye kakhulu, futhi okusebenza kahle kumuntu oyedwa kungase kungabi kuhle komunye. Thembela eqenjini lakho lokunakekelwa kwezempilo ukuthi likuqondise ngalezi zinqumo ngokusekelwe ocwaningweni lwakamuva kanye nephrofayili yakho yezempilo.
Kokubili i-gilteritinib ne-midostaurin bangama-FLT3 inhibitors, kodwa ngokuvamile asetshenziswa ezimweni ezihlukene kunokuthi ziqhathaniswe ngokuqondile njengezinketho ezingcono noma ezimbi kakhulu. Ukukhetha phakathi kwazo kuncike ezimweni zakho ezithile kanye nomlando wokwelashwa.
I-Midostaurin ivame ukusetshenziswa kanye ne-chemotherapy njengokwelashwa kokuqala kwe-AML esanda kutholwa ene-FLT3 mutations. I-Gilteritinib, ngakolunye uhlangothi, ngokuvamile igcinelwe abantu i-AML yabo ebuyele ngemva kokwelashwa kwangaphambilini noma engazange iphendule kwezinye izindlela zokwelapha.
Ezinye izifundo zikhomba ukuthi i-gilteritinib ingase ibe namandla amakhulu ekuvimbeleni amaprotheni e-FLT3, kodwa lokhu akukwenzi ngokushesha kube ngcono kuwo wonke umuntu. Udokotela wakho ucabangela izici eziningi okuhlanganisa impilo yakho yonke, ukwelashwa kwangaphambilini, nokuthi umdlavuza wakho othile uziphatha kanjani lapho ekhetha imithi efanele.
Into okubaluleke kakhulu ukuthola ukwelashwa okusebenzela kangcono isimo sakho somuntu ngamunye. Ithimba lakho lokunakekelwa kwezempilo lizokusiza ukuthi uqonde ukuthi kungani bekhethe omunye umuthi kunomunye ngokusekelwe ocwaningweni lwamanje kanye nomlando wakho wezokwelapha.
I-Gilteritinib idinga ukuqapha ngokucophelela kubantu abanezimo zenhliziyo ezikhona, njengoba ngezinye izikhathi ingathinta ukushaya kwenhliziyo nomsebenzi wayo. Udokotela wakho uzohlola impilo yenhliziyo yakho ngaphambi kokuqala ukwelashwa futhi akuqaphe ngokucophelela kuyo yonke leyo nkathi.
Uma unezifo zenhliziyo, ithimba lakho lokunakekelwa kwezempilo cishe lizokwenza izivivinyo ezijwayelekile zomsebenzi wenhliziyo, okuhlanganisa ama-electrocardiograms (EKGs) futhi mhlawumbe nama-echocardiograms. Bangase futhi basebenze nodokotela wezinhliziyo ukuqinisekisa ukuthi isimo senhliziyo yakho silawulwa kahle ngesikhathi sokwelashwa komdlavuza.
Ungavumeli izinkinga zenhliziyo zikuvimbele ukuthi uxoxe ngale ndlela yokwelashwa nodokotela wakho. Abantu abaningi abanezimo zenhliziyo bangayithatha ngokuphepha i-gilteritinib ngokuqapha okufanele nokuphathwa.
Uma ngengozi uthatha i-gilteritinib eningi kunaleyo ebekiwe, xhumana nomhlinzeki wakho wezempilo noma isikhungo sokulawula ubuthi ngokushesha. Ungalindi ukubona ukuthi uzizwa ugula, njengoba isenzo esisheshayo sibalulekile ngemithi yomdlavuza.
Ngesikhathi ulindele isiqondiso sezokwelapha, ungazami ukuzenza uhlanze ngaphandle uma uyalelwe ngqo ukwenza kanjalo. Gcina ibhodlela lomuthi nawe ukuze ukwazi ukunikeza imininingwane eqondile ngalokho nokuthi uthathe okungakanani.
Ithimba lakho lokunakekelwa kwezempilo lingase lifune ukukuqapha eduze ngenxa yemiphumela emibi noma lilungise isimiso sakho sokwelashwa. Banolwazi ekubhekaneni namaphutha emithi futhi bazokwazi izinyathelo ezingcono kakhulu zokuthatha ukuphepha kwakho.
Uma uphuthelwa umthamo we-gilteritinib, yithathe ngokushesha nje lapho ukhumbula, ngaphandle uma sekuseduze isikhathi somthamo wakho olandelayo. Kuleso simo, weqa umthamo ophuthelwe bese uqhubeka neshejuli yakho ejwayelekile.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe, ngoba lokhu kungakhuphula ingozi yakho yemiphumela emibi. Uma ungaqiniseki ngesikhathi, xhumana nethimba lakho lezempilo ukuze uthole isiqondiso kunokuthi uqagele.
Cabangela ukusetha i-alamu yansuku zonke noma usebenzise umhleli wamaphilisi ukukusiza ukuthi ukhumbule imithi yakho. Ukuqina kubalulekile ukuze i-gilteritinib isebenze ngempumelelo ngokuphikisana ne-leukemia yakho.
NguDokotela wakho kuphela onganquma ukuthi kuphephile nini ukuyeka ukuthatha i-gilteritinib. Lesi sinqumo sisekelwe ekutheni i-leukemia yakho isabela kahle kangakanani ekwelashweni, impilo yakho yonke, nemiphumela ehlukahlukene yokuhlolwa ngokuhamba kwesikhathi.
Ithimba lakho lezempilo lizobheka intuthuko yakho ngokuhlolwa kwegazi njalo kanye nokuhlolwa komnkantsha wamathambo. Lokhu kuhlolwa kubasiza ukuthi baqonde ukuthi imithi isasebenza yini nokuthi umzimba wakho uyisingatha kahle yini.
Abanye abantu bangase badinge ukuthatha i-gilteritinib izinyanga eziningi noma iminyaka, kanti abanye bangase bashintshele ekwelashweni okuhlukile noma bathole ukuxolelwa okubavumela ukuthi bayeke. Thembela eqenjini lakho lezempilo ukuthi likuqondise ngalezi zinqumo ngokusekelwe ekuphenduleni kwakho ngakunye ekwelashweni.
Abantu abaningi bangashayela ngokuphepha ngenkathi bethatha i-gilteritinib, kodwa kufanele unake ukuthi imithi ikuthinta kanjani wena mathupha. Abanye abantu bahlangabezana nesiyezi, ukukhathala, noma izinguquko zombono ezingathinta ikhono labo lokushayela ngokuphepha.
Qala ngokuthi omunye umuntu akuqhubele emaphoyintimenti ngesikhathi samaviki akho ambalwa okuqala okwelashwa. Lokhu kukunika isikhathi sokuthi uqonde ukuthi i-gilteritinib ikuthinta kanjani ngaphambi kokungena ngemuva kwesondo.
Uma uzwa isiyezi, ukukhathala okukhulu, noma izinkinga zokubona, gwema ukushayela kuze kube yilapho lezi zimpawu zithuthuka. Njalo qinisekisa ukuphepha kwakho kanye nokuphepha kwabanye emgwaqeni.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.